The global electronic health records (EHR) market is projected to grow from $34.2 billion in 2023 to $52.2 billion by 2030, expanding at a 7.4% compound annual growth rate (CAGR) during 2025–2030, BCC Research said in its report Global Markets and Technologies for Electronic Health Records (HLC205B). Growth is being driven by rising chronic disease prevalence, including diabetes, cardiovascular conditions, cancer and neurological disorders, which require coordinated, data-intensive care across specialties. North America remains the largest regional market, accounting for 43.5% of global revenue, supported by mature healthcare IT infrastructure, regulatory frameworks such as HIPAA (U.S. health data privacy law), and extensive hospital digitization in the United States and Canada. Government mandates and national digital health programs are pushing paper-based facilities toward electronic systems, while public funding is supporting healthcare IT modernization in developed and emerging economies. Cloud-based software-as-a-service (SaaS) deployment is lowering upfront costs for small and mid-sized practices and providing remote access, continuous updates and improved interoperability. Artificial intelligence, natural language processing and FHIR (a standard for exchanging health data) are emerging as key areas of EHR innovation, supporting automated documentation, predictive analytics and health information exchange. BCC Research identified Epic Systems Corp., Oracle, Medical Information Technology Inc. (MEDITECH), Veradigm LLC, TruBridge, eClinicalWorks, Netsmart Technologies Inc., Athenahealth, CompuGroup Medical, AdvancedMD Inc., NXGN Management LLC., CureMD Healthcare, Greenway Health LLC, McKesson Corp. and Medsphere Systems Corp. as key market participants. The report presents the market as a long-term investment opportunity supported by regulatory demand, recurring SaaS revenue and expansion across mature and emerging markets, while identifying cybersecurity vulnerabilities, implementation costs and fragmented legacy systems as material risks. Vendors with interoperability capabilities, AI-integrated platforms and specialty modules for areas such as oncology, cardiology and neurology are described as best positioned for premium segments.